Kura Oncology, Inc.
corporate_fare Company Profile
Kura Oncology, Inc. (NASDAQ:KURA) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 27 items for KURA at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Kura Oncology's Darlifarnib Shows 44% ORR, 94% DCR in Difficult-to-Treat Kidney Cancer Patients
- Shareholders to Vote on Significant Equity Plan Expansion and Executive Compensation
- Kura Oncology Reports First Product Revenue for KOMZIFTI™ Following FDA Approval, Details Robust Pipeline Expansion
- Kura Oncology Reports First Product Revenue, $195M in Milestones, and Strong Cash Runway Despite Increased Q4 Net Loss
- Kura Oncology Reports Q4 Net Loss of $81 Million, Operating Expenses Exceed $100 Million
Financial Snapshot
Fiscal year ended December 31, 2025
Revenue
$67.48M
Net Income
-$278.67M
Diluted EPS
-$3.18
Op. Cash Flow
-$64.06M
Free Cash Flow
-$70.7M
Operating Income
-$303.63M
Cash & Equivalents
$149.1M
Total Debt
$9.71M
Debt / Equity
0.06×
Net Margin
-412.9%
Shares Outstanding
87.86M sh
Source: 10-K · filed 2026-03-05 · accession 0001193125-26-092567
show_chartPrice Chart
Loading chart...
feed KURA - Filings & News (Page 2)
KURA
Apr 17, 2026, 6:00 AM EDT
Price at Filing:
$9.00
Real-time Price:
$6.94
Change:
-$2.06 (-23%)
Market Cap:
$634.882M
KURA
Apr 10, 2026, 4:25 PM EDT
Price at Filing:
$8.67
Real-time Price:
$6.94
Change:
-$1.73 (-20%)
Market Cap:
$634.882M
KURA
Mar 05, 2026, 7:31 AM EST
Price at Filing:
$8.07
Real-time Price:
$6.94
Change:
-$1.13 (-14%)
Market Cap:
$634.882M
KURA
Mar 05, 2026, 6:35 AM EST
Price at Filing:
$8.50
Real-time Price:
$6.94
Change:
-$1.56 (-18%)
Market Cap:
$634.882M
KURA
Mar 05, 2026, 6:31 AM EST
Price at Filing:
$8.54
Real-time Price:
$6.94
Change:
-$1.60 (-19%)
Market Cap:
$634.882M
KURA
Jan 29, 2026, 5:25 PM EST
Price at Filing:
$8.22
Real-time Price:
$6.94
Change:
-$1.28 (-16%)
Market Cap:
$634.882M
KURA
Jan 12, 2026, 6:05 AM EST
Price at Filing:
$9.58
Real-time Price:
$6.94
Change:
-$2.64 (-28%)
Market Cap:
$634.882M